The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Coronary interventions
Left main or proximal left anterior descending coronary artery disease location identifies high-risk patients deriving potentially greater benefit from prolonged dual antiplatelet therapy duration
EuroIntervention 2016;11:e1222-e1230 - published online ahead of print August 2015 - published online e-edition February 2016. DOI: 10.4244/EIJY15M08_04
Francesco Costa1, MD; Marianna Adamo1, MD; Sara Ariotti1, MD; Giuseppe Ferrante2, MD, PhD; Eliano Pio Navarese3, MD, PhD; Sergio Leonardi4, MD; Hector Garcia-Garcia5, MD, PhD; Pascal Vranckx6, MD, PhD; Marco Valgimigli1*, MD, PhD
1. Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands; 2. Interventional Cardiology, Humanitas Clinical and Research Institute IRCCS, Milan, Italy; 3. Department of Internal Medicine, Division of Cardiology, Pulmonology and Vascular Medicine
Aims: It is currently unclear if the location of coronary artery disease affects decision making with regard to dual antiplatelet therapy (DAPT). We investigated if the presence of at lea